Atlas Trials

Retinal Structural and Functional Changes in Patients Treated With BRAF/MEK Inhibitors

Clinical trial NCT07431489 · COMPLETED

Trial details

NCT number
NCT07431489
Sponsor
Institute of Oncology Ljubljana
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Malignant MelanomaMEK Inhibitor-Associated Retinopathy
Start date
2023-11-01
Primary completion
2025-01-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.